ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

YS YS Biopharma Company Ltd

0.96
0.01 (1.05%)
最終更新日: 01:02:55
15分遅延
名称 銘柄コード 市場 種別
YS Biopharma Company Ltd YS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 1.05% 0.96 01:02:55
始値 安値 高値 終値 前日終値
0.94 0.94 1.02 0.95
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0805:20PRNUSYS Biopharma to Hold Extraordinary General Meeting on May..
2024/4/2921:00PRNUSYS Biopharma Receives Additional 180 Day Extension by Nasdaq..
2024/4/1920:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
2024/4/1821:00PRNUSYS Biopharma Granted Phase I Clinical Trial License of..
2024/4/1621:00PRNUSYS Biopharma to Report First Nine Months of Fiscal Year 2024..
2024/4/0921:00PRNUSYS Biopharma Announces Positive Interim Results of Pivotal..
2024/4/0321:00PRNUSYS Biopharma Announces Full Repayment of US$40,000,000 Loan..
2024/3/0522:00PRNUSYS Biopharma Announces Board Changes and Strategic..
2024/2/2307:00PRNUSYS Biopharma Announces Results of Extraordinary General..
2024/2/1818:30PRNUS/C O R R E C T I O N -- YS Biopharma Co., Ltd./
2024/2/1710:20PRNUSYS Biopharma Announces Results of Extraordinary General..
2024/2/1422:00PRNUSYS Biopharma to Hold an Extraordinary General Meeting on..
2024/2/1421:50PRNUSYS Biopharma Announces Appointment of New Directors
2024/2/1222:50PRNUSYS Biopharma Responds to a Notice of Extraordinary General..
2024/2/0920:30PRNUSYS Biopharma Announces US$40 Million Private Placement..
2024/2/0908:10PRNUSShareholders of YS Biopharma Announce an Extraordinary..
2024/1/2307:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
2024/1/0822:00PRNUSYS Biopharma Announces Changes to its Board Committees
2023/12/2106:30PRNUSYS Biopharma Responds to Unauthorized Press Release..
2023/12/2022:56PRNUSYS Biopharma Co., Ltd. to Hold Extraordinary General Meeting..
2023/11/1422:30PRNUSNoble Capital Markets Initiates Coverage on YS Biopharma..
2023/10/3121:30PRNUSYS Biopharma Announces Completion of Subject Enrollment in..
2023/10/2621:30PRNUSYS Biopharma Announces Receipt of Nasdaq Notice
2023/9/2621:30PRNUSYS Biopharma Announces First Subject Enrollment in Pivotal..
2023/9/1521:30PRNUSYS Biopharma Granted Patent in the U.S. for Immunotherapy..
2023/9/0521:30PRNUSYS Biopharma to Participate in Participate in Citi's 18th..
2023/8/2505:15PRNUSYS Biopharma Announces Purchase of Shares by Company..
2023/8/1606:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
2023/7/2706:00PRNUSYS Biopharma Announces Financial Results for Fiscal Year..
2023/7/2205:30PRNUSYS Biopharma to Report Financial Results for Fiscal Year..
2023/6/0121:30PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..
2023/5/1821:25PRNUSYS Biopharma to Participate in the Virtual Benchmark..
2023/5/1620:00PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..

最近閲覧した銘柄

Delayed Upgrade Clock